OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pro-phagocytic function and structural basis of GPR84 signaling
Xuan Zhang, Yujing Wang, Shreyas Supekar, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 19

Showing 19 citing articles:

MDSCs-derived GPR84 induces CD8+T-cell senescence via p53 activation to suppress the antitumor response
Jinyan Liu, Jiayin Liu, Guohui Qin, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 11, pp. e007802-e007802
Open Access | Times Cited: 19

Metabolite-sensing GPCRs in rheumatoid arthritis
Xuezhi Yang, Wankang Zhang, Luping Wang, et al.
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 2, pp. 118-133
Closed Access | Times Cited: 4

Synthetic GPR84 Agonists in Colorectal Cancer: Effective in THP-1 Cells but Ineffective in BMDMs and MC38 Mouse Tumor Models
Marlene Schwarzfischer, Marion Walker, Michele Curcio, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 490-490
Open Access

An update on regulation and function of G protein-coupled receptors in cancer: A promising strategy for cancer therapy
Lin Li, Zihao An, Chao Lin, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189266-189266
Closed Access

In situ Global Mapping of Protein Perturbations via Protein Abundance and Conformation Analysis
Yi Li, Xiaoliu Yang, Fei Zheng, et al.
Analytica Chimica Acta (2025) Vol. 1349, pp. 343827-343827
Closed Access

Minimal Structural Variation of GPR84 Full Agonist Causes Functional Switch to Inverse Agonism
Loukas Ieremias, Asmita Manandhar, Katrine Schultz-Knudsen, et al.
Journal of Medicinal Chemistry (2025)
Closed Access

Cryo-EM as a tool for illuminating activation mechanisms of human class A orphan GPCRs
Isabella C. Russell, Dongju Lee, Denise Wootten, et al.
Pharmacological Reviews (2025), pp. 100056-100056
Open Access

GPCRs in chronic respiratory diseases
Zlatko Brkljača, Vesna Eraković, Sanja Koštrun, et al.
Elsevier eBooks (2025)
Closed Access

Structure–Activity Relationship Studies and Optimization of 4-Hydroxypyridones as GPR84 Agonists
Loukas Ieremias, Mads H. Kaspersen, Asmita Manandhar, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 5, pp. 3542-3570
Closed Access | Times Cited: 1

Development of Highly Potent, G-Protein Pathway Biased, Selective, and Orally Bioavailable GPR84 Agonists
Pinqi Wang, Arun Raja, Vincent B. Luscombe, et al.
Journal of Medicinal Chemistry (2023) Vol. 67, Iss. 1, pp. 110-137
Open Access | Times Cited: 3

Biased agonists of GPR84 and insights into biological control
Vincent B. Luscombe, Pinqi Wang, Angela J. Russell, et al.
British Journal of Pharmacology (2023) Vol. 181, Iss. 10, pp. 1509-1523
Open Access | Times Cited: 3

Editorial for GPR84 pharmacology
Graeme Milligan
British Journal of Pharmacology (2024) Vol. 181, Iss. 10, pp. 1497-1499
Open Access

Molecular characterization of GPR84 in domestic cats
Ichiro Yamamoto, Masaki Michishita, Κ. Fujita, et al.
General and Comparative Endocrinology (2024) Vol. 353, pp. 114520-114520
Open Access

The GPR84 Antagonist GLPG1205 Reduces Features of Disease in Experimental Severe Asthma
Chantal Donovan, Andrew E. Thorpe, Henry M. Gomez, et al.
American Journal of Respiratory Cell and Molecular Biology (2024) Vol. 70, Iss. 5, pp. 424-427
Closed Access

Orphan GPCRs in Neurodegenerative Disorders: Integrating Structural Biology and Drug Discovery Approaches
June‐Ki Kim, Chulwon Choi
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 10, pp. 11646-11664
Open Access

Signal regulatory protein beta 2 is a novel positive regulator of innate anticancer immunity
Nienke Visser, Levi Collin Nelemans, Yuan He, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 1

Page 1

Scroll to top